FDA Inspection 1257778 — Aquestive Therapeutics Inc.
The FDA completed an inspection of Aquestive Therapeutics Inc. on Dec 6, 2024 in Warren, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Dec 6, 2024
- Fiscal Year
- 2025
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Warren, NJ (United States)
Additional details
Postmarket Adverse Drug Experience (PADE)